|
HY-108645-5mg
|
MedChemexpress LLC
|
AL 8697 [CAS 1057394-06-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108645-1mL
|
MedChemexpress LLC
|
AL 8697 [CAS 1057394-06-5] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14362-1mg
|
MedChemexpress LLC
|
GSK-25 [CAS 874119-56-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14362-10mg
|
MedChemexpress LLC
|
GSK-25 [CAS 874119-56-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14362-25mg
|
MedChemexpress LLC
|
GSK-25 [CAS 874119-56-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14362-5mg
|
MedChemexpress LLC
|
GSK-25 [CAS 874119-56-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14362-50mg
|
MedChemexpress LLC
|
GSK-25 [CAS 874119-56-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14362-1mL
|
MedChemexpress LLC
|
GSK-25 [CAS 874119-56-9] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501-10mg
|
MedChemexpress LLC
|
ITI-214 (free base) [CAS 1160521-50-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501-5mg
|
MedChemexpress LLC
|
ITI-214 (free base) [CAS 1160521-50-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501-50mg
|
MedChemexpress LLC
|
ITI-214 (free base) [CAS 1160521-50-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501A-10mg
|
MedChemexpress LLC
|
ITI-214 [CAS 1642303-38-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501A-5mg
|
MedChemexpress LLC
|
ITI-214 [CAS 1642303-38-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501A-50mg
|
MedChemexpress LLC
|
ITI-214 [CAS 1642303-38-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501A-1mL
|
MedChemexpress LLC
|
ITI-214 [CAS 1642303-38-5] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-131868-1mg
|
MedChemexpress LLC
|
TRPV3 antagonist 74a [CAS 1432051-63-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-131868-5mg
|
MedChemexpress LLC
|
TRPV3 antagonist 74a [CAS 1432051-63-2]
|
|
Neuroscience-Neuromodulation
|
|
